| Literature DB >> 22988934 |
Holger Cramer1, Silke Lange, Petra Klose, Anna Paul, Gustav Dobos.
Abstract
BACKGROUND: Many breast cancer patients and survivors use yoga to cope with their disease. The aim of this review was to systematically assess and meta-analyze the evidence for effects of yoga on health-related quality of life and psychological health in breast cancer patients and survivors.Entities:
Mesh:
Year: 2012 PMID: 22988934 PMCID: PMC3527138 DOI: 10.1186/1471-2407-12-412
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Complete search strategy for Medline
| Yoga | (yoga[MeSH Terms] OR yog*[Title/Abstract]) |
| | AND |
| Health-related quality of life or psychological health | (quality of life[MeSH Terms] OR quality of life[Title/Abstract] OR well-being[Title/Abstract] OR mental health[MeSH Terms] OR mental health[Title/Abstract] OR psychological health[Title/Abstract] OR anxiety[MeSH Terms] OR anxiety[Title/Abstract] OR depressive disorder[MeSH Terms] OR depression[Title/Abstract] OR stress[Title/Abstract] OR distress[Title/Abstract] OR affect[MeSH Terms] OR mood[Title/Abstract]) |
| | AND |
| Breast cancer | (breast neoplasms[MeSH Terms] OR (breast[Title/Abstract] AND (neoplasms[Title/Abstract] OR cancer[Title/Abstract] OR oncology[Title/Abstract]))) |
Figure 1Flowchart of the results of the literature search.
Characteristics of the included studies
| Banasik et al., 2011
[ | 18 | 62.9 | II-IV | At least 2 month post-treatment | Iyengar Yoga: yoga postures | Wait-list, no treatment | Health-related quality of life (FACT-B) | No significant effects. |
| 8 weeks, twice weekly, 90 minutes | 8 weeks | a) Week 8 | ||||||
| b) NA | ||||||||
| Banerjee et al., 2007
[ | 68 | 44 | II-III | Radiotherapy | Integrated yoga program: yoga postures, deep relaxation, breathing techniques, meditation, guided imagery, group awareness | Supportive counseling and advice to take light exercise | Anxiety (HADS) | Significant short-term effects on anxiety (p < 0.001), depression (p < 0.001), perceived stress (p < 0.001). |
| 6 weeks, frequency NR, 90 minutes | 6 weeks, frequency and duration NR | Depression (HADS) | ||||||
| Perceived stress (PSS) | ||||||||
| a) Week 6 | ||||||||
| b) NA | ||||||||
| Blank et al., 2003
[ | 18 | NR | I-III | Antiestrogen or aromatase inhibitor, at least 8 weeks post-chemotherapy | Iyengar yoga: yoga postures, deep relaxation, meditation, chanting | Wait-list, no treatment | Questionnaire regarding perceived stress, psychological outcomes | No group comparison. |
| 8 weeks, twice weekly, duration NR | 8 weeks | a) Week 6 | ||||||
| b) NA | ||||||||
| Bower et al., 2011
[ | 31 | 53.9 | 0-II | No local and/or adjuvant cancer therapy | Iyengar yoga: postures, breathing techniques | Health education | Vitality (SF-36) | Significant short-term effects on depression (p = 0.026). |
| 12 weeks, twice weekly, 90 minutes | 12 weeks, once weekly, 120 minutes | Depression (BDI) | Clinically important long-term effects on vitality. | |||||
| Perceived stress (PSS) | ||||||||
| a) weeks 12 to 14 | ||||||||
| b) week 24 | ||||||||
| Carson et al., 2009
[ | 37 | 54.4 | I-II | No current chemotherapy or hormone replacement therapy | Yoga of Awareness: yoga postures, breathing techniques, meditation, study of pertinent topics, group discussion | Wait-list, no treatment | Daily diary regarding negative mood, symptom-related distress | Significant short-term effects on symptom-related distress (p < 0.0001). |
| 8 weeks, once weekly, 120 minutes | 8 weeks | a) Week 6 | Significant long-term effects on symptom-related distress (p < 0.0001) and negative mood (p < 0.0001). | |||||
| b) Week 20 | ||||||||
| Chandwani et al., 2010
[ | 81 | NR | 0-III | Radiotherapy | Yoga based on Patanjali`s yoga sutras: yoga postures, deep relaxation, breath control, meditation | Wait-list, no treatment | Health-related quality of life (SF-36) | Significant short-term effects on SF-36 physical component score (p = 0.04), general health (p = 0.005), physical function (p = 0.04). |
| 6 weeks, twice weekly, 60 minutes | 6 weeks | Depression (CES-D) | No significant long-term effects. | |||||
| Anxiety (STAI) | ||||||||
| Intrusion/avoidance (IES) | ||||||||
| a) Week 7 | ||||||||
| b) Week 18 | ||||||||
| Danhauer et al., 2009
[ | 44 | 55.8 | Any | Any | Restorative yoga: yoga postures, breathing techniques, deep relaxation, meditation | Wait-list, no treatment | Health-related quality of life (FACT-B, FACIT-Sp, SF-12) | Significant short-term effects on mental well-being (p = 0.004), spiritual well-being (p = 0.0009), depression (p = 0.026), positive affect (p = 0.01). |
| 10 weeks, once weekly, 75 minutes | 10 weeks | Depression (CES-D) | ||||||
| Positive and negative affect (PANAS) | ||||||||
| a) Week 10 | ||||||||
| b) NA | ||||||||
| Kovačič & Kovačič, 2011
[ | 32 | NR | I-II | Radiotherapy, chemotherapy | Yoga in Daily Life® System: breathing techniques, deep relaxation, progressive muscle relaxation, meditation | Standard physiotherapy | Mental well-being (GHQ-12) | Significant short-term effects on mental well-being (p < 0.0005), perceived stress (p < 0.0005). |
| 1 week, 7 times a week, 45 minutes | 1 week | Psychological distress (RSCL) | Significant long-term effects on mental well-being (p < 0.0005), psychological distress (p < 0.0005), perceived stress (p < 0.0005). | |||||
| Standard physiotherapy | Perceived stress (PSS) | |||||||
| 1 week | a) Week 2 | |||||||
| b) Week 5 | ||||||||
| Littman et al., 2011
[ | 63 | 60.6 | 0-III | At least 3 month post-treatment | Viniyoga: yoga postures, breathing techniques, deep relaxation, meditation | Wait-list, no treatment | Health-related quality of life (FACT-B) | No significant effects. |
| 6 months, 1 to 3 times a week 75 minutes | 6 month | a) Week 48 | ||||||
| b) NA | ||||||||
| Moadel et al., 2007
[ | 164 | 54.81 | I-III | Any | Hatha yoga: yoga postures, breathing, techniques, meditation | Wait-list, no treatment | Health-related quality of life (FACT-G, FACIT-Sp) | Significant short-term effect on social well-being (p < 0.018). |
| 12 weeks, once weekly, 90 minutes | 12 weeks | Anxiety (Distressed Mood Index) | ||||||
| Psychological distress (Distressed Mood Index) | ||||||||
| a) Week 12 | ||||||||
| b) Week 24 (NR) | ||||||||
| Raghavendra et al., 2007
[ | 98 | NR | II-III | Chemotherapy | Integrated yoga program: yoga postures, breathing techniques, relaxation with imagery, chanting | Brief supportive therapy | Health-related quality of life (FLIC) | Significant short-term effects on overall health-related quality of life (p < 0.001), anxiety (p < 0.001), depression (p < 0.001), symptom distress (p < 0.001). |
| Program length NR, 30 minutes 4 times, 60 minutes every 10 days | Program length NR, 60 minutes once, 30 minutes every 10 days | Anxiety (STAI) | ||||||
| Depression (BDI) | ||||||||
| Symptom distress (Subjective Symptom Checklist) | ||||||||
| a) NR | ||||||||
| b) NA | ||||||||
| Vadiraja et al., 2009
[ | 88 | 47.23 | II-III | Radiotherapy | Integrated yoga program: yoga postures, breathing techniques, relaxation with imagery, meditation | Brief supportive therapy | Health-related quality of life (EORTC QLQ-C30) Anxiety (HADS) Depression (HADS) Positive and negative affect (PANAS) | Significant short-term effects on emotional function (p = 0.001), cognitive function (p = 0.03), anxiety (p < 0.001), depression (p = 0.002), positive affect (p = 0.007), negative affect (p < 0.001), perceived stress (p < 0.001), psychological distress (p < 0.001). |
| 6 weeks, 60 minutes at least 3 times a week (18–24 session in total) | 6 weeks, 15 minutes every 10 days (3–4 sessions in total) | |||||||
| Perceived stress (PSS) | ||||||||
| Psychological distress (RSCL) | ||||||||
| a) Week 6 | ||||||||
| b) NA |
Abbreviations: BDI: Beck’s Depression Inventory; CES-D: Center of Epidemiologic Studies Depression Scale; EORTC QLQ-C30: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30; FACT: Functional Assessment of Cancer Therapy (B: Breast; G: General; Sp: Spirituality); FLIC: Functional Living Index for Cancer; GHQ-12: General Health Questionnaire-12; HADS: Hospital Anxiety and Depression Scale; IES: Impact of Events Scale; PANAS: Positive & negative affect schedule; PSS: support cancer care; RSCL: Rotterdam Symptom Checklist; STAI: State Trait Anxiety Inventory; SF-36/-12: Medical Outcomes Study 36/12-item short-form survey; NA: not applicable; NR: not reported.
Risk of bias assessment of the included studies using the Cochrane risk of bias tool
| Banasik et al., 2011
[ | Unclear | Unclear | High risk | Unclear | Low risk | Low risk | Low risk |
| Banerjee et al., 2007
[ | Low risk | Low risk | High risk | Unclear | High risk | Low risk | Low risk |
| Blank et al., 2003
[ | Unclear | Unclear | High risk | Unclear | High risk | High risk | High risk |
| Bower et al., 2011
[ | Low risk | Low risk | High risk | Low risk | Low risk | Low risk | Low risk |
| Carson et al., 2009
[ | Low risk | Low risk | High risk | Low risk | Low risk | Low risk | Low risk |
| Chandwani et al., 2010
[ | Low risk | Unclear | High risk | Unclear | Low risk | Low risk | Low risk |
| Danhauer et al., 2009
[ | Unclear | Unclear | High risk | Unclear | Low risk | Low risk | Low risk |
| Kovačič & Kovačič, 2011
[ | Low risk | Low risk | Low risk | Low risk | Unclear | Low risk | Low risk |
| Littman et al., 2011
[ | Low risk | Unclear | High risk | High risk | Low risk | Low risk | Low risk |
| Moadel et al., 2007
[ | Unclear | Unclear | High risk | Unclear | Low risk | Low risk | Low risk |
| Raghavendra et al., 2007
[ | Low risk | Low risk | High risk | Unclear | High risk | Low risk | Low risk |
| Vadiraja et al., 2009
[ | Low risk | Low risk | High risk | Unclear | High risk | High risk | Low risk |
Figure 2Effect sizes of yoga versus controls on health-related quality of life: general quality of life, mental, physical, social, and spiritual well-being.
Figure 3Effect sizes of yoga versus controls on psychological health: anxiety, depression, perceived stress, and psychological distress.
Effect sizes of yoga versus no treatment and active control interventions
| Global quality of life | 3 | 127 | 85 | 0.29 [0.01, 0.57] | 0.04 | 0%; 0.75; 0.69 |
| Mental well-being | 5 | 161 | 123 | 0.09 [−0.15, 0.33] | 0.46 | 0%; 3.40; 0.49 |
| Physical well-being | 5 | 161 | 123 | 0.51 [−0.33, 1.34] | 0.23 | 89%; 37.26; <0.01 |
| Functional well-being | 4 | 134 | 92 | 0.30 [0.03, 0.57] | 0.03 | 0%; 1.14; 0.77 |
| Social well-being | 3 | 161 | 123 | 0.32 [0.08, 0.56] | <0.01 | 0%; 3.49; 0.48 |
| Spiritual well-being | 2 | 97 | 58 | 0.41 [0.08, 0.74] | 0.01 | 0%; 0.11; 0.74 |
| Anxiety | 2 | 111 | 75 | −0.58 [−1.22, 0.07] | 0.08 | 75%; 3.93; 0.05 |
| Depression | 2 | 40 | 45 | −0.35 [−0.81, 0.12] | 0.14 | 11%; 1.12; 0.29 |
| Psychological distress | 3 | 124 | 89 | −0.19 [−0.70, 0.32] | 0.47 | 64%; 5.55; 0.06 |
| Mental well-being | 2 | 63 | 60 | 1.19 [0.13, 2.26] | 0.03 | 81%; 5.9; 0.02 |
| Anxiety | 3 | 105 | 90 | −2.21 [−3.90, -0.52] | 0.01 | 95%; 42.26; <0.01 |
| Depression | 4 | 121 | 105 | −2.29 [−3.97, -0.61] | <0.01 | 96%; 74.01; <0.01 |
| Perceived stress | 3 | 93 | 71 | −1.14 [−2.16, -0.12] | 0.03 | 88%; 16.42; <0.01 |
| Psychological distress | 3 | 91 | 94 | −1.55 [−2.48, -0.61] | <0.01 | 85%; 13.68; <0.01 |
aOutcomes are only shown when sufficient data for meta-analysis were available.
Effect sizes of yoga versus control during active cancer treatment and after completion of active cancer treatment
| Mental well-being | 3 | 90 | 91 | 1.01 [−0.19, 2.22] | 0.10 | 92%; 24.89; <0.01 |
| Physical well-being | 3 | 81 | 82 | 1.22 [−0.90, 3.34] | 0.26 | 97%; 28.66; <0.01 |
| Social well-being | 2 | 74 | 75 | 0.38 [−0.02, 0.78] | 0.06 | 31%; 1.46; 0.23 |
| Anxiety | 4 | 132 | 121 | −1.86 [−3.02, -0.69] | <0.01 | 93%; 45.00;<0.01 |
| Depression | 4 | 132 | 121 | −2.16 [−3.77, -0.55] | <0.01 | 96%; 83.03; <0.01 |
| Perceived stress | 3 | 93 | 72 | −2.13 [−3.48, -0.78] | <0.01 | 91%; 21.38; <0.01 |
| Psychological distress | 4 | 113 | 114 | −1.10 [−2.09, -0.10] | 0.03 | 92%; 35.97; <0.01 |
| Mental well-being | 2 | 37 | 34 | −0.16 [−0.63, 0.31] | 0.50 | 0%; 0.04; 0.85 |
| Physical well-being | 2 | 37 | 34 | 0.07 [−0.68, 0.81] | 0.86 | 44%; 1.77; 0.18 |
| Functional well-being | 2 | 37 | 34 | 0.23 [−0.23, 0.70] | 0.33 | 0%; 0.05; 0.82 |
| Social well-being | 2 | 37 | 34 | 0.05 [−0.50, 0.61] | 0.85 | 16%; 1.20; 0.27 |
aOutcomes are only shown when sufficient data for meta-analysis were available.